Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits.
about
Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practiceThe evaluation of three treatment protocols using oral prednisone and oral meloxicam for therapy of canine idiopathic lymphoplasmacytic rhinitis: a pilot studyEvolving role of pharmaceutical physicians in medical evidence and education
P2860
Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Coprescribing proton-pump inhi ...... drugs: risks versus benefits.
@en
Coprescribing proton-pump inhi ...... drugs: risks versus benefits.
@nl
type
label
Coprescribing proton-pump inhi ...... drugs: risks versus benefits.
@en
Coprescribing proton-pump inhi ...... drugs: risks versus benefits.
@nl
prefLabel
Coprescribing proton-pump inhi ...... drugs: risks versus benefits.
@en
Coprescribing proton-pump inhi ...... drugs: risks versus benefits.
@nl
P2093
P2860
P356
P1476
Coprescribing proton-pump inhi ...... drugs: risks versus benefits.
@en
P2093
Graca Lima
Kok Ann Gwee
Sajita Setia
Vernadine Goh
P2860
P304
P356
10.2147/JPR.S156938
P577
2018-02-14T00:00:00Z